Real-time enrollment status for this advanced cancer clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 1:57 AM UTC
| NCT Number | NCT06921928 |
| Recruiting Status | Recruiting |
| Condition | Advanced Cancer |
| Phase | PHASE1 |
| Target Enrollment | 117 participants |
| Active Locations | 3 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | June 16, 2026 (Jun 16, 2026) |
As of July 20, 2026: Clinical trial NCT06921928 is currently recruiting participants. This phase1 study for advanced cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06921928 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06921928 was last updated Jun 16, 2026 (June 16, 2026). HelloStudys verifies this status automatically.